Clarification of Number of Health Care System Partners Required for RFA-RM-16-019 NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)

Notice Number: NOT-RM-17-007

Key Dates
Release Date: January 17, 2017

Related Announcements
RFA-RM-16-019

Issued by
National Institutes of Health (NIH)
Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this notice is to correct a discrepancy in the number of health care system partners that must be identified for a Demonstration Project. The modification corrects the number listed in the Funding Opportunity Purpose section, and relates that trials should be conducted across at least three health care systems (HCS) unless a strong, scientific rationale for limiting this aspect of the project is provided. The Funding Opportunity Purpose is the only section of the FOA that mis-states this number. Text addressing the number of HCS partners in the remainder of the FOA (Part 2. Full Text of Announcement, Section1. Funding Opportunity Description, Research Objectives) relates that applicants must identify at least three health care system partners unless strong scientific rationale is provided.

Part 1. Overview Information

Funding Opportunity Purpose

Currently Reads:

The purpose of this FOA is to solicit applications to support Demonstration Projects that include an efficient, large-scale pragmatic clinical trial. Trials must be conducted across two or more health care systems (HCS) and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. (See https://commonfund.nih.gov/hcscollaboratory). Awards made through this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible rapid transition to the second implementation phase (UH3) for a pragmatic trial Demonstration Project. UH3s will be awarded after administrative review of eligible UG3s that have met the scientific milestone and feasibility requirements necessary for the UH3 implementation phase, depending on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA. 

The overall goal of the NIH HCS Research Collaboratory program is to strengthen the national capacity to implement cost-effective, large-scale research studies that engage health care delivery organizations as research partners. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS.  After awards are made by NIH, the CCC (https://www.nihcollaboratory.org/Pages/default.aspx) and the NIH will work with successful awardees from this FOA to facilitate the planning and rapid execution of high impact Demonstration Projects that conduct research studies in partnerships with health care delivery systems, ultimately making available data, tools and resources from Collaboratory research projects to develop a broadened base of research partnerships with HCS.

Modified to Read:

Funding Opportunity Purpose

The purpose of this FOA is to solicit applications to support Demonstration Projects that include an efficient, large-scale pragmatic clinical trial. Trials should be conducted across at least three health care systems (HCS) unless a strong, scientific rationale for limiting this aspect of the project is provided, and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. (See https://commonfund.nih.gov/hcscollaboratory). Awards made through this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible rapid transition to the second implementation phase (UH3) for a pragmatic trial Demonstration Project. UH3s will be awarded after administrative review of eligible UG3s that have met the scientific milestone and feasibility requirements necessary for the UH3 implementation phase, depending on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA. 

The overall goal of the NIH HCS Research Collaboratory program is to strengthen the national capacity to implement cost-effective, large-scale research studies that engage health care delivery organizations as research partners. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS.  After awards are made by NIH, the CCC (https://www.nihcollaboratory.org/Pages/default.aspx) and the NIH will work with successful awardees from this FOA to facilitate the planning and rapid execution of high impact Demonstration Projects that conduct research studies in partnerships with health care delivery systems, ultimately making available data, tools and resources from Collaboratory research projects to develop a broadened base of research partnerships with HCS.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Robin Boineau, M.D.
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-435-6286
Email: hcsrs-pt@nih.gov